Clinical Trials Logo

Vomiting clinical trials

View clinical trials related to Vomiting.

Filter by:

NCT ID: NCT03627780 Completed - Clinical trials for Genetic Predisposition to Disease

Genetic Polymorphism and Post Operative Nausea and Vomiting (PONV)

ponv
Start date: January 2, 2017
Phase:
Study type: Observational

Nausea and vomiting affects 25-30% of individuals in the post-operative period and can reach more than 70-80% in high-risk patients. inherited factors may play a significant role in individual susceptibility and clinical research on hereditary factors involved in the pathogenesis of Postoperative nausea and vomiting (PONV) and chemotherapy nausea and vomiting (CINV) is relatively new. The aim of this study is to investigate whether inter-individual differences related to PONV are associated with genetic factors. 300 patients will be evaluated in postoperative oncological surgeries. The peripheral leukocyte DNA will be extracted by the Salting Out Procedure method and processed to genotyping for 48 SNPs from 15 candidate genes by real-time PCR by the Taqman method. The possible associations with demographic data and factors related to surgery will be analyzed by univariate and multivariate analysis.

NCT ID: NCT03626441 Completed - Clinical trials for Postoperative Nausea and Vomiting

The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting

Start date: December 2, 2017
Phase: Phase 2
Study type: Interventional

This study evaluates the effectiveness of ginger on the incidence of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Half the patients were given an oral dose of ginger preoperatively and half received placebo.

NCT ID: NCT03621722 Completed - Anxiety Clinical Trials

AroMatherapy for Blood and Marrow Transplant PatIENTs (AMBIENT)

AMBIENT
Start date: February 27, 2017
Phase: N/A
Study type: Interventional

The study is comparing the difference between the use of Elequil Aromatabs versus standard of care practice treatments on Blood Marrow Transplantation patients.

NCT ID: NCT03603119 Completed - Clinical trials for Postoperative Nausea and Vomiting

Midazolam Versus Dexamethasone-ondansetron in Preventing Postoperative Nausea-vomiting for Laparoscopic Surgeries

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Postoperative nausea and vomiting(PONV) affects 11 to 60 % of patients undergoing surgery and is a major cause of postoperative morbidity. Risk factors include female gender, non smokers, postoperative use of opioids and a past history of PONV. The simplified Apfel risk score is used to identify patients at risk for PONV. PONV prophylaxis is provided intraoperatively to patients with 2 or more risk factors. In spite of numerous drugs available, control of PONV remains a difficult task. Midazolam is a commonly used drug perioperatively for its anxiolytic and sedative properties. It decreases analgesic requirement and has also been found to have an antiemetic effect. This present study is designed to compare the prophylactic use of iv midazolam with a commonly used combination of dexamethasone-ondansetron in high risk patients (as defined by the modified Apfel score) undergoing laparoscopic surgeries.

NCT ID: NCT03601871 Recruiting - Clinical trials for Chemotherapy-induced Nausea and Vomiting

The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy

Start date: July 12, 2018
Phase: N/A
Study type: Interventional

This is a pragmatic randomized, multi-center, open-label randomized clinical trial, aimed to evaluate efficacy and safety of thalidomide in improving prevention of chemotherapy-induced delayed nausea and vomiting (CINV) in chemotherapy-naive patients after multi-cycle cisplatin-containing highly emetogenic chemotherapy (HEC) .

NCT ID: NCT03599687 Completed - Vomiting Clinical Trials

Soiled Airway Tracheal Intubation and the Effectiveness of Decontamination by Paramedics

SATIATED
Start date: July 16, 2018
Phase:
Study type: Observational

In more than one-in-five cases of out-of-hospital cardiac arrest, airways are blocked by vomit and blood. Sometimes, paramedics cannot clear the airway using methods they have been taught. If the airway cannot be cleared, the patient will die. Usually, these patients will have a breathing tube placed into their windpipe (intubation), as this provides protection from vomit and blood. To do this, the paramedic needs to be able to see the entrance to the windpipe. A new method of clearing the airway called SALAD has been used in patients to help insert a breathing tube, but it is not known whether the method can help paramedics. This study will use a manikin to see if paramedics can insert a breathing tube more often on their first attempt, using SALAD.

NCT ID: NCT03588338 Completed - Clinical trials for Postoperative Nausea and Vomiting

Paracetamol on Postoperative Nausea and Vomiting

Start date: July 20, 2018
Phase: Phase 4
Study type: Interventional

The drugs with both high potency and low side effects are preferred in the prevention of postoperative nausea and vomiting (PONV) which is a common problem. This prospective randomized study aimed to compare the efficacy of paracetamol on PONV in adults undergoing maxillofacial surgery.

NCT ID: NCT03586817 Recruiting - Clinical trials for Nausea and Vomiting, Postoperative

PALONOSETRON X FOSAPREPITANT IN PONV

Start date: March 2, 2019
Phase: Phase 4
Study type: Interventional

Cholelithiasis (presence of gallbladder stones) is prevalent in 10 to 15% of the world population. This disease can lead to serious complications such as cholecystitis, cholangitis and pancreatitis. Video-laparoscopic cholecystectomy (CVL) is considered the gold standard treatment of this condition. Despite ongoing research and development of new drugs and techniques, postoperative nausea and vomiting (PONV) are frequent, lead to unexpected hospitalizations, delay hospital discharge, increase hospital costs, and cause patient dissatisfaction. Video-laparoscopic surgeries are cited in the literature as a risk factor for PONV, with an incidence of up to 75% in cases where prophylactic drugs are not used.Through the simplified Apfel score, it is possible to determine the risk for PONV. This risk classification is based on four risk factors: female gender, non-smoking, postoperative use of opioids and previous history of PONV. The incidence of PONV would be 10%, 20%, 40%, 60% and 80%, respectively, if none, one, two, three or four risk factors are present. Antiemetics recommended for prophylaxis of PONV in adults include 5-hydroxytryptamine (5-HT3) receptor antagonists (ondansetron, dolasetron, granisetron, tropisetron, ramosetron and palonosetron), neurokinin-1 (NK-1) receptor antagonists (aprepitant), (dendrohydrin and haloperidol), antihistamines (dimenhydrin and meclizine), and anticholinergics (scopolamine).

NCT ID: NCT03583489 Completed - Clinical trials for Postoperative Nausea and Vomiting

Study of APD421 With and Without Ondansetron

Start date: July 17, 2018
Phase: Phase 1
Study type: Interventional

Collection of pharmacokinetic and electrocardiograph data from healthy volunteers given APD421 +/- ondansetron

NCT ID: NCT03578952 Terminated - Clinical trials for Aortic Valve Insufficiency

Evaluation of Effectiveness and Safety of Evolut R Valve In Patients With Pure Aortic Regurgitation

Pure AR TAVR
Start date: August 10, 2018
Phase: N/A
Study type: Interventional

This study is to evaluate the efficacy and safety of transcatheter aortic valve replacement (TAVR) in severe 'pure Aortic regurgitation (AR)' using Evolut R valve (Medtronic, Minneapolis, MN).